MoherD, HopewellS, SchulzKF,CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ2010; 340:c869.
2.
CollinsR, MacMahonS. Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials. Lancet2001; 357:373–80.
3.
Sharp Collaborative Group.Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am Heart J2010; 160:785–94.
4.
AltmanDG, HrynaszkiewiczI, FurbergCD, GrimshawJM, RothwellPM. Five years of Trials. Trials2011; 12:248.
5.
DachsRJ, BurtonJH, JoslinJ. A User's Guide to the NINDS rt-PA Stroke Trial Database. PLoS Med2008; 5:e113.
6.
SandercockP, NiewadaM, CzlonkowskaA. The International Stroke Trial database. Trials2011; 12:101.
7.
WhiteleyW, LindleyR, WardlawJ, SandercockP., International Stroke Trial Collaborative Group. Third International Stroke Trial. Int J Stroke2006; 1:172–6.
8.
SandercockP, LindleyR, WardlawJ,, Collaborative Group. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. Trials2011; 12:252.
9.
WardlawJM, MurrayV, BergeE, Del ZoppoGJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev2009; (4)CD000213.
